Premium
How genetic studies have advanced our understanding of age‐related macular degeneration and their impact on patient care: a review
Author(s) -
Baird Paul N,
Chakrabarti Subhabrata
Publication year - 2013
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1111/ceo.12235
Subject(s) - macular degeneration , medicine , disease , epigenetics , bioinformatics , computational biology , ophthalmology , genetics , pathology , biology , gene
The last 10 years have seen an unprecedented explosion in our knowledge regarding the genomic basis of age‐related macular degeneration. This has come about through major advances in computing power, microfabrication of large numbers of molecular markers on chips and improved statistical algorithms for analysis. In tandem, it has become clear that age‐related macular degeneration appears to be a multifactorial disease with influences from genetic and structural variants, as well as epigenetic involvement. The combination of these factors with known environmental determinants indicates the highly complex nature of this disease, but at the same time also offers insights into risk prediction and disease stratification through genotype profiling.